In erythroderma, malignant cells showed strong increases in CXCL13 compared to both patch and plaque lesions (Fig. 7 I-J, Table S13), previously described to be highly upregulated in Sézary cells [39]. This evidence concerns the gene CXCL13 and exfoliative dermatitis.